GC Biotech Japan

A mission to make biotechnology innovation more accessible, equitable, and clinically meaningful.

We aim to bridge advanced scientific research with practical healthcare solutions that improve early diagnosis, precision treatment, and long-term public health outcomes across diverse populations.

Portrait of Santosh Gothwal, Founder and CEO of GC Biotech

Dr. Santosh Kumar Gothwal, PhD

Founder & CEO

GC Biotech Japan

Founder Profile & CEO Message

We live in an era where scientific innovation is advancing rapidly, yet its equitable application remains a critical challenge. The challenge today is not only whether biotechnology can deliver groundbreaking discoveries, but whether these breakthroughs can reach broader populations and improve healthcare in practical, sustainable ways. Our mission is to connect cutting-edge scientific progress with healthcare solutions that are accessible, scalable, and impactful for all.

Our services support research across academic institutions and industrial settings through specialized expertise in molecular biology and biotechnological applications. By collaborating closely with healthcare organizations, physicians, and oncologists, we are dedicated to advancing next-generation cancer therapies, including mutation analysis and chemotherapeutic drug testing for improved treatment outcomes. We also focus on biomarker discovery, targeted therapies, early cancer detection, and advanced prenatal and postnatal genetic analysis to strengthen precision medicine approaches.

As a first step, we seek collaboration with specialized service providers in translational research and medical devices to contribute to improving healthcare infrastructure globally. Our contract research services are designed to support both academic and industrial biotechnology projects, addressing real research challenges with practical solutions. We believe healthcare advances must not remain the privilege of a few, our guiding principle is healthcare justice, delivering scientific solutions responsibly and fairly across global populations.

Santosh Gothwal

Founder & CEO

Mission in Action

The principles guiding our work

Our mission is built around accessible healthcare innovation, meaningful scientific translation, and long-term benefit for broader populations.

Equitable Access

Making advanced biotechnology solutions accessible beyond limited systems.
Expanding reach to diverse populations through scalable and practical approaches.

Preventive Care

Strengthening early detection and risk identification through modern diagnostics.
Reducing long-term disease burden with proactive and data-driven healthcare strategies.

Translational Medicine

Bridging laboratory discoveries with real clinical applications.
Converting research insights into actionable diagnostics and therapies.

Team and Network

A growing structure built around complementary expertise

Shama Bansod

Director, Contract Research

Leading contract research activities with focus on applied biotechnology workflows and collaborative research execution.

Dr. Kanikkai A Raja

Senior Scientist — NIH

Stem cell research and transplantation therapies for diabetes.

Licensing and Credentials

GC Biotech certificates and supporting documents for its marketing partners globally

GC Biotech certificate document 1
GC Biotech certificate document 2
GC Biotech certificate document 3

Our experienced marketing partners can assure your product delivery

Distribution and operational experience that strengthens future execution potential

Established expertise

  • • More than 20 years of experience in distribution of medical devices, life-saving drugs, and diagnostic kits.
  • • End-to-end supply chain management experience with emphasis on delivery continuity and customer trust.
  • • Operational familiarity with time-sensitive and regulated healthcare products.

Business and network strength

  • • Long-term business growth built through sustained healthcare-sector relationships in India.
  • • Experience working with hospitals, diagnostic laboratories, and pharma-linked partners.
  • • Broad client-network relevance across both government and private healthcare sectors.